Companies / Integra Lifesciences Holdings Corp
Integra Lifesciences Holdings Corp
Nasdaq: IARTCIK 917520PRINCETON, NJ
Financials · FY2025
Ownership
77.8M shares outstanding · as of Jul 28, 2026
Ownership
| Insiders | 0.66% | 510,166 |
| 10%+ / strategic | 9.84% | 7,649,058 |
| Institutions | 88.61% | 68,916,645 |
| Public float | 0.90% | 696,637 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 13
View all →| Insider | % of shares | Shares |
|---|---|---|
Hill Barbara BDirector | 0.19% | 151,191 |
Bradley KeithDirector | 0.11% | 88,254 |
Davis Robert T. Jr.EVP & President, TT | 0.09% | 66,387 |
McBreen Michael J.EVP & President, CSS | 0.08% | 60,743 |
Knight Lea DanielsEVP & Chief Financial Officer | 0.06% | 50,489 |
Mosebrook JeffreySVP, Fin & Princ Acct Officer | 0.05% | 35,453 |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL | 0.05% | 35,422 |
Veillon-Berteloot ChantalEVP & CHRO | 0.03% | 22,227 |
Poul MojdehCEOPresident & CEO · Director | 0.00% | 0 |
Essig StuartCEOPresident and CEO · Director | — | — |
Institutional holders 215
View all →| Holder | Value | % of shares |
|---|---|---|
| $191.89M | 13.74% | |
| $96.30M | 9.97% | |
| $89.56M | 9.27% | |
| $52.93M | 3.79% | |
| $47.81M | 4.95% | |
| $43.75M | 4.53% | |
| $38.35M | 3.97% | |
| $37.80M | 5.16% | |
| $33.25M | 4.54% | |
| $25.82M | 2.67% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Paradigm Capital Management INC/NY 13F manager | Add | Common stock | $12.70M | +1.3M +50.57% | 4,012,698 5.16% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $6.04M | +336K +3.25% | 10,684,103 13.74% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Add | Common stock | $5.25M | +558K +409.28% | 694,076 0.89% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common stock | $4.46M | +474K +318.10% | 622,853 0.80% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-4.25M | -74K -68.32% | 34,297 0.04% of shares | low |
| Q2 2026 as of | Victory Capital Management, Inc. 13F manager | Trim | Common stock | $-3.09M | -172K -86.82% | 26,143 0.03% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common stock | $2.90M | +160K +634.70% | 184,903 0.24% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common stock | $2.50M | +201K +32.21% | 825,101 1.06% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Fuller & Thaler Asset Management, Inc. | Passive13G/A | — |
| Paradigm Capital Management INC/NY | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| IART | — | 457985208 |